Multiple sclerosis (MS) is a progressive, debilitating, and immune-mediated neurodegenerative disorder where the myelin sheath – the insulating cover of all neurons – in the central nervous system (CNS) becomes damaged due to inflammation.

The body’s immune system attacks the myelin (the fatty substance that surrounds and insulates the nerve fibers) when the T-cells cross the blood-brain barrier to attack the epitopes presented by the myelin sheath cells. As a result, many experts believe MS should more appropriately be termed an immune-mediated disease rather than an autoimmune disease, as the exact target of these T-cells and the cause of their behavior remains unknown.

This attack disturbs and progressively destroys the conduction of nerve impulses, leading to scarring and permanent damage to the myelin sheath and the nerve fibers, and resulting in severe neurodegenerative complications such as impaired vision, loss of senses, loss of balance, loss of control over voluntary muscles, and all other bodily functions connected to the CNS. A classic hallmark of MS is the exacerbation or flare-ups of symptoms which occur repeatedly over months or years in the relapsing-remitting form of the disease.

Researchers are constantly seeking a cure for MS. Current medications treat symptoms and flare-ups, but do not guarantee long-term effects.

Proper diagnosis and a thorough check-up can help a physician zero in on the possibility of an MS diagnosis, along with MRI and CSF testing to show typical scars or plaque in the brain considered to be the most definitive way to confirm multiple sclerosis. MS has the potential of causing severe damage in its initial phases of attacks. The earlier treatment starts, the more effective it is for the patient.

Since the condition is serious and progressive, there is also an issue of emotional stress. Clinicians have noted that it is very important that friends and family of MS patients provide as much support as possible. It is vital that MS patients maintain a healthy lifestyle to prevent additional flare-ups.

Epidemiology of multiple sclerosis

MS affects from 2 million to 2.5 million people around the world; women are affected two or three times as often as men. It generally affects people between the ages 20 and 50. The average age of diagnosis of MS is 29 for women and 31 for men. According to data provided by the National MS Society, an estimated 400,000 people in the U.S. are affected by MS. But this is just an estimate, as the CDC does not require physicians in the U.S. to report new cases of MS, and the symptoms are also not pronounced during the initial stages. The prevalence estimate varies between 58 to 95 per 100,000 people.

It has been observed in epidemiological studies that prevalence estimates of people with MS increase with latitude, implying that people living farthest from the equator (such as Northern Europe) are more prone to MS than people living near the equator. However, there have been theories that defy this theory. Proof in favor come from the fact that Parsis, Sardinians, and Palestinians are more susceptible to multiple sclerosis than Chinese, Japanese, and African people. Migration also plays a key role in determining susceptibility. Immigrants moving to high-risk areas are more prone to being affected with MS. Apart from being most common in Caucasians, Latin Americans are also shown to have high chances of acquiring MS, according to independent studies.

Etiology of multiple sclerosis:

There are a number of hypotheses for the causes of MS, but the exact cause has not yet been discovered by researchers. Etiological factors constitute a complex web of gender, ethnicity, and heredity, with infectious diseases and environmental factors also playing roles.

In the U.S., people generally have a 0.1 percent chance of developing MS. But for a person with MS, his or her family members and all first degree familial connections are at an increased risk of developing the disease. Siblings, children, and non-identical twins of this person are at a 2% to 5% risk of developing MS, whereas identical twins (with the same set of genes as the patient) have a 25% chance of developing MS. This implies that the remaining 75% are affected by geography, ethnicity and other environmental factors. So, people with a genetic predisposition react to specific environmental factors which trigger the immune response against the CNS.

Another theory refers to polymorphisms and their effects in generation of immune response. Polymorphism refers to different forms of the same genes. They lead to encoding of different amounts of similar proteins and products. A single nucleotide polymorphism (SNP) might exist in a gene responsible for immune response (which is supposed to be the predisposing gene for MS) which leads to an alteration of the amount of product formed which might be so severe that it triggers an exaggerated immune response toward an antigen, leading to massive secretion of pro-inflammatory cytokines. This might lead to an automatic immune response towards the CNS. Research has been ongoing to find a genetic connection in favor of MS. So far, the HLA-DRB1 gene of the Human Leukocyte Antigen (HLA) located on the human chromosome 6 has been linked to increased susceptibility to MS. Complementing it, studies have also hinted at the role of the gene HLA-C*05,  also located on the same chromosome, in conferring protection against MS.

Exposure to various viruses occurs in childhood. One of them, the Epstein-Barr Virus (EBV), has been shown to cause demyelination and inflammation of nerve fibers. It is possible that the virus adopts molecular mimicry, and cross-reactivate the T-cells targeted against their viral epitope with those on the myelin sheath. This is why there is a huge influx of T-cells across the blood brain barrier.

Again, these are all mere assumptions, as a number of other infectious agents have been assumed to have an impact on the development of MS, and EBV is just one of them. It can also be said that the immunocompromised host affected by these viral infections is more susceptible to an immune mediated condition like MS.

Another observation from studies involving MS susceptibility suggests that immigrants, if moved to an area of higher incidence later in life from a low-risk area, have a lower risk of developing MS. It is only during early childhood, up to the age of about 15, does the susceptibility to MS directly rely upon the risk associated with the area where a person lives.

Vitamin D deficiencies have also been linked to the increased susceptibility to MS. Vitamin D is responsible for maintaining a balance between pro- and anti-inflammatory cytokines, with the downregulation of the former and the upregulation of the latter. Sunlight is an essential provider of vitamin D. This might explain why people living in higher latitudes with low incidence of sunlight are more prone to developing MS than those living at lower latitudes (closer to the equator) who have more stable vitamin D levels.

Smoking has also been attributed to increased susceptibility to MS. Smokers are at an increased risk of developing MS, but if people quit smoking even after the first incidence of symptomatic attacks, their chances of progressive MS are decreased.

The factors believed to be responsible for the development of MS appear to be interrelated and interdependent, which paves the way for an ambiguity in determining the independent roles of each factor.

Read more about multiple multiple sclerosis symptoms.

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.